{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:42:13Z","timestamp":1792759333314,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00467-019-04400-w","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:03:41Z","timestamp":1573067021000},"page":"493-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Treatment of hyperphosphatemia: the dangers of high PTH levels"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-2529","authenticated-orcid":false,"given":"Justine","family":"Bacchetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"4400_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1681\/ASN.2011111115","volume":"23","author":"MM Mitsnefes","year":"2012","unstructured":"Mitsnefes MM (2012) Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23:578\u2013585. https:\/\/doi.org\/10.1681\/ASN.2011111115","journal-title":"J Am Soc Nephrol"},{"key":"4400_CR2","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483. https:\/\/doi.org\/10.1056\/NEJM200005183422003","journal-title":"N Engl J Med"},{"key":"4400_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945\u20131953. https:\/\/doi.org\/10.1038\/sj.ki.5000414","journal-title":"Kidney Int"},{"key":"4400_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney Int 92:26\u201336. https:\/\/doi.org\/10.1016\/j.kint.2017.04.006","journal-title":"Kidney Int"},{"key":"4400_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.ki.5001606","volume":"70","author":"J-C Souberbielle","year":"2006","unstructured":"Souberbielle J-C, Boutten A, Carlier M-C, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P (2006) Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 70:345\u2013350. https:\/\/doi.org\/10.1038\/sj.ki.5001606","journal-title":"Kidney Int"},{"key":"4400_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000350149","volume":"37","author":"B Hocher","year":"2013","unstructured":"Hocher B, Oberth\u00fcr D, Slowinski T, Querfeld U, Schaefer F, Doyon A, Tepel M, Roth HJ, Gr\u00f6n HJ, Reichetzeder C, Betzel C, Armbruster FP (2013) Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients. Kidney Blood Press Res 37:240\u2013251. https:\/\/doi.org\/10.1159\/000350149","journal-title":"Kidney Blood Press Res"},{"key":"4400_CR7","doi-asserted-by":"publisher","unstructured":"Vervloet MG, Brandenburg VM, CKD-MBD working group of ERA-EDTA (2017) Circulating markers of bone turnover. J Nephrol 30:663\u2013670. https:\/\/doi.org\/10.1007\/s40620-017-0408-8","DOI":"10.1007\/s40620-017-0408-8"},{"key":"4400_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Ure\u00f1a Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90:1184\u20131190. https:\/\/doi.org\/10.1016\/j.kint.2016.06.041","journal-title":"Kidney Int"},{"key":"4400_CR9","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s00467-014-3017-y","volume":"30","author":"L Rees","year":"2015","unstructured":"Rees L, Shroff R (2015) The demise of calcium-based phosphate binders-is this appropriate for children? Pediatr Nephrol 30:2061\u20132071. https:\/\/doi.org\/10.1007\/s00467-014-3017-y","journal-title":"Pediatr Nephrol"},{"key":"4400_CR10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ki.2010.316","volume":"78","author":"D Borzych","year":"2010","unstructured":"Borzych D, Rees L, Ha IS, Bak M, Rees L, Cano F, Munarriz RL, Chua A, Pesle S, Emre S, Urzykowska A, Quiroz L, Ruscasso JD, White C, Pape L, Ramela V, Printza N, Vogel A, Kuzmanovska D, Simkova E, M\u00fcller-Wiefel DE, Sander A, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (IPPN) Registry (2010) The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int 78:1295\u20131304. https:\/\/doi.org\/10.1038\/ki.2010.316","journal-title":"Kidney Int"},{"key":"4400_CR11","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl:S1\u2013S130. https:\/\/doi.org\/10.1038\/ki.2009.188","DOI":"10.1038\/ki.2009.188"},{"key":"4400_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A, Fischbach M, R\u00f6nnholm K, Schaefer F, Simkova E, Stefanidis CJ, Strazdins V, Vande Walle J, Schr\u00f6der C, Zurowska A, Ekim M, European Pediatric Dialysis Working Group (EPDWG) (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21:151\u2013159. https:\/\/doi.org\/10.1007\/s00467-005-2082-7","journal-title":"Pediatr Nephrol"},{"key":"4400_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ki.2010.352","volume":"79","author":"K Wesseling-Perry","year":"2011","unstructured":"Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang HJ, Elashoff R, J\u00fcppner H, Salusky IB (2011) Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int 79:112\u2013119. https:\/\/doi.org\/10.1038\/ki.2010.352","journal-title":"Kidney Int"},{"key":"4400_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00467-008-0838-6","volume":"23","author":"S Waller","year":"2008","unstructured":"Waller S, Shroff R, Freemont AJ, Rees L (2008) Bone histomorphometry in children prior to commencing renal replacement therapy. Pediatr Nephrol 23:1523\u20131529. https:\/\/doi.org\/10.1007\/s00467-008-0838-6","journal-title":"Pediatr Nephrol"},{"key":"4400_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV, Bakkaloglu S, Cozzolino M, Bacchetta J, Edefonti A, Stefanidis CJ, Vande Walle J, Ariceta G, Klaus G, Haffner D, Schmitt CP, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups (2017) Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant 32:1114\u20131127. https:\/\/doi.org\/10.1093\/ndt\/gfx080","journal-title":"Nephrol Dial Transplant"},{"key":"4400_CR16","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.11.017","volume":"53","author":"KDOQI Work Group","year":"2009","unstructured":"KDOQI Work Group (2009) KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 53:S11-104. https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.017","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"4400_CR17","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00467-018-3978-3","volume":"33","author":"E Preka","year":"2018","unstructured":"Preka E, Ranchin B, Doyon A, Vierge M, Ginhoux T, Kassai B, Bacchetta J (2018) The interplay between bone and vessels in pediatric CKD: lessons from a single-center study. Pediatr Nephrol. 33(9):1565\u20131575. https:\/\/doi.org\/10.1007\/s00467-018-3978-3","journal-title":"Pediatr Nephrol."},{"key":"4400_CR18","doi-asserted-by":"publisher","unstructured":"Hahn D, Hodson EM, Craig JC (2015) Interventions for metabolic bone disease in children with chronic kidney disease. Cochrane Database Syst Rev CD008327. https:\/\/doi.org\/10.1002\/14651858.CD008327.pub2","DOI":"10.1002\/14651858.CD008327.pub2"},{"key":"4400_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00467-012-2347-x","volume":"28","author":"R Shroff","year":"2013","unstructured":"Shroff R (2013) Phosphate is a vascular toxin. Pediatr Nephrol 28:583\u2013593. https:\/\/doi.org\/10.1007\/s00467-012-2347-x","journal-title":"Pediatr Nephrol"},{"key":"4400_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1681\/ASN.2011121191","volume":"24","author":"R Shroff","year":"2013","unstructured":"Shroff R, Long DA, Shanahan C (2013) Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 24:179\u2013189. https:\/\/doi.org\/10.1681\/ASN.2011121191","journal-title":"J Am Soc Nephrol"},{"key":"4400_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mad.2010.02.008","volume":"131","author":"M Kuro-o","year":"2010","unstructured":"Kuro-o M (2010) A potential link between phosphate and aging--lessons from Klotho-deficient mice. Mech Ageing Dev 131:270\u2013275. https:\/\/doi.org\/10.1016\/j.mad.2010.02.008","journal-title":"Mech Ageing Dev"},{"key":"4400_CR22","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1681\/ASN.2010020221","volume":"21","author":"OM Guti\u00e9rrez","year":"2010","unstructured":"Guti\u00e9rrez OM, Anderson C, Isakova T, Scialla J, Negrea L, Anderson AH, Bellovich K, Chen J, Robinson N, Ojo A, Lash J, Feldman HI, Wolf M, CRIC Study Group (2010) Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 21:1953\u20131960. https:\/\/doi.org\/10.1681\/ASN.2010020221","journal-title":"J Am Soc Nephrol"},{"key":"4400_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ki.2013.3","volume":"83","author":"JJ Scialla","year":"2013","unstructured":"Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, Hamano T, Master SR, Nessel L, Chai B, Xie D, Kallem RR, Chen J, Lash JP, Kusek JW, Budoff MJ, Giachelli CM, Wolf M, Chronic Renal Insufficiency Cohort Study Investigators (2013) Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 83:1159\u20131168. https:\/\/doi.org\/10.1038\/ki.2013.3","journal-title":"Kidney Int"},{"key":"4400_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120856","volume":"10","author":"RC Pereira","year":"2015","unstructured":"Pereira RC, J\u00fcppner H, Gales B, Salusky IB, Wesseling-Perry K (2015) Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients. PLoS One 10:e0120856. https:\/\/doi.org\/10.1371\/journal.pone.0120856","journal-title":"PLoS One"},{"key":"4400_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Dr\u00fceke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators (2015) Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation 132:27\u201339. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013876","journal-title":"Circulation"},{"key":"4400_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela ALE, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moys\u00e9s RM (2010) Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol 5:286\u2013291. https:\/\/doi.org\/10.2215\/CJN.05420709","journal-title":"Clin J Am Soc Nephrol"},{"key":"4400_CR27","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2215\/CJN.03030317","volume":"12","author":"S Liabeuf","year":"2017","unstructured":"Liabeuf S, Ryckelynck J-P, El Esper N, Ure\u00f1a P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Pri\u00e9 D, Choukroun G (2017) Randomized clinical trial of sevelamer carbonate on serum klotho and fibroblast growth factor 23 in CKD. Clin J Am Soc Nephrol 12:1930\u20131940. https:\/\/doi.org\/10.2215\/CJN.03030317","journal-title":"Clin J Am Soc Nephrol"},{"key":"4400_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000440968","volume":"131","author":"A Iguchi","year":"2015","unstructured":"Iguchi A, Kazama JJ, Yamamoto S, Yoshita K, Watanabe Y, Iino N, Narita I (2015) Administration of ferric citrate hydrate decreases circulating FGF23 levels independently of serum phosphate levels in hemodialysis patients with iron deficiency. Nephron 131:161\u2013166. https:\/\/doi.org\/10.1159\/000440968","journal-title":"Nephron"},{"key":"4400_CR29","doi-asserted-by":"publisher","unstructured":"Bacchetta J, Bardet C, Pri\u00e9 D (2019) Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2019.01.006","DOI":"10.1016\/j.metabol.2019.01.006"},{"key":"4400_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00467-018-4054-8","volume":"34","author":"WY Sohn","year":"2019","unstructured":"Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA (2019) An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to <\u20096 years with chronic kidney disease receiving dialysis. Pediatr Nephrol 34:145\u2013154. https:\/\/doi.org\/10.1007\/s00467-018-4054-8","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"4400_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00467-018-4116-y","volume":"34","author":"BA Warady","year":"2018","unstructured":"Warady BA, Iles JN, Ariceta G, Dehmel B, Hidalgo G, Jiang X, Laskin B, Shahinfar S, Vande Walle J, Schaefer F (2018) A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol. 34(3):475\u2013486. https:\/\/doi.org\/10.1007\/s00467-018-4116-y","journal-title":"Pediatr Nephrol."},{"key":"4400_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jama.2017.16477","volume":"319","author":"J Kim","year":"2018","unstructured":"Kim J, Ross JS, Kapczynski A (2018) Pediatric exclusivity and regulatory authority: implications of amgen v HHS. JAMA 319:21\u201322. https:\/\/doi.org\/10.1001\/jama.2017.16477","journal-title":"JAMA"},{"key":"4400_CR33","doi-asserted-by":"publisher","unstructured":"Bacchetta J, Schmitt CP, Ariceta G, Bakkaloglu S, Groothoof J, Wan M, Vervloet M, Shroff R, Haffner D; ESPN and CKD-MBD working groups of the ERA-EDTA (2019) Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfz159","DOI":"10.1093\/ndt\/gfz159"},{"key":"4400_CR34","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1038\/s41598-018-21397-8","volume":"8","author":"G Wang","year":"2018","unstructured":"Wang G, Liu H, Wang C, Ji X, Gu W, Mu Y (2018) Cinacalcet versus placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis. Sci Rep 8:3111. https:\/\/doi.org\/10.1038\/s41598-018-21397-8","journal-title":"Sci Rep"},{"key":"4400_CR35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Dehmel B, Goodman WG, Dr\u00fceke TB, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators (2015) Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol 26:1466\u20131475. https:\/\/doi.org\/10.1681\/ASN.2014040414","journal-title":"J Am Soc Nephrol"},{"key":"4400_CR36","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2215\/CJN.02110216","volume":"11","author":"AA Portale","year":"2016","unstructured":"Portale AA, Wolf MS, Messinger S, Perwad F, J\u00fcppner H, Warady BA, Furth SL, Salusky IB (2016) Fibroblast growth factor 23 and risk of CKD progression in children. Clin J Am Soc Nephrol 11:1989\u20131998. https:\/\/doi.org\/10.2215\/CJN.02110216","journal-title":"Clin J Am Soc Nephrol"},{"key":"4400_CR37","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370\u20131378. https:\/\/doi.org\/10.1038\/ki.2011.47","journal-title":"Kidney Int"},{"key":"4400_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/ndt\/gfx065","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV, Bakkaloglu S, Fischer DC, Bishop N, Cozzolino M, Bacchetta J, Edefonti A, Stefanidis CJ, Vande Walle J, Haffner D, Klaus G, Schmitt CP, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups (2017) Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant 32:1098\u20131113. https:\/\/doi.org\/10.1093\/ndt\/gfx065","journal-title":"Nephrol Dial Transplant"},{"key":"4400_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2215\/CJN.04760511","volume":"7","author":"R Shroff","year":"2012","unstructured":"Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, Wells D, Aitkenhead H, Manickavasagar B, van't Hoff W, Rees L (2012) Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 7:216\u2013223. https:\/\/doi.org\/10.2215\/CJN.04760511","journal-title":"Clin J Am Soc Nephrol"},{"key":"4400_CR40","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/jbmr.427","volume":"26","author":"RJ Wetzsteon","year":"2011","unstructured":"Wetzsteon RJ, Kalkwarf HJ, Shults J, Zemel BS, Foster BJ, Griffin L, Strife CF, Foerster DL, Jean-Pierre DK, Leonard MB (2011) Volumetric bone mineral density and bone structure in childhood chronic kidney disease. J Bone Miner Res 26:2235\u20132244. https:\/\/doi.org\/10.1002\/jbmr.427","journal-title":"J Bone Miner Res"},{"key":"4400_CR41","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jc.2012-4188","volume":"98","author":"MR Denburg","year":"2013","unstructured":"Denburg MR, Tsampalieros AK, de Boer IH, Shults J, Kalkwarf HJ, Zemel BS, Foerster D, Stokes D, Leonard MB (2013) Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab 98:1930\u20131938. https:\/\/doi.org\/10.1210\/jc.2012-4188","journal-title":"J Clin Endocrinol Metab"},{"key":"4400_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00467-012-2270-1","volume":"28","author":"D Haffner","year":"2013","unstructured":"Haffner D, Schaefer F (2013) Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies. Pediatr Nephrol 28:537\u2013545. https:\/\/doi.org\/10.1007\/s00467-012-2270-1","journal-title":"Pediatr Nephrol"},{"key":"4400_CR43","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Guti\u00e9rrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408. https:\/\/doi.org\/10.1172\/JCI46122","journal-title":"J Clin Invest"},{"key":"4400_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1681\/ASN.2015020152","volume":"27","author":"MR Denburg","year":"2016","unstructured":"Denburg MR, Kumar J, Jemielita T, Brooks ER, Skversky A, Portale AA, Salusky IB, Warady BA, Furth SL, Leonard MB (2016) Fracture burden and risk factors in childhood CKD: results from the CKiD cohort study. J Am Soc Nephrol 27:543\u2013550. https:\/\/doi.org\/10.1681\/ASN.2015020152","journal-title":"J Am Soc Nephrol"},{"key":"4400_CR45","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.2215\/CJN.01330210","volume":"5","author":"SA Bakkaloglu","year":"2010","unstructured":"Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB (2010) Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol 5:1860\u20131866. https:\/\/doi.org\/10.2215\/CJN.01330210","journal-title":"Clin J Am Soc Nephrol"},{"key":"4400_CR46","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2215\/CJN.05940611","volume":"7","author":"K Wesseling-Perry","year":"2012","unstructured":"Wesseling-Perry K, Pereira RC, Tseng C-H, Elashoff R, Zaritsky JJ, Yadin O, Sahney S, Gales B, Juppner H, Salusky IB (2012) Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol 7:146\u2013152. https:\/\/doi.org\/10.2215\/CJN.05940611","journal-title":"Clin J Am Soc Nephrol"},{"key":"4400_CR47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.2215\/CJN.00330112","volume":"8","author":"J Bacchetta","year":"2013","unstructured":"Bacchetta J, Wesseling-Perry K, Kuizon B, Pereira RC, Gales B, Wang HJ, Elashoff R, Salusky IB (2013) The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial. Clin J Am Soc Nephrol 8:824\u2013832. https:\/\/doi.org\/10.2215\/CJN.00330112","journal-title":"Clin J Am Soc Nephrol"},{"key":"4400_CR48","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/ndt\/gfs299","volume":"27","author":"J Bacchetta","year":"2012","unstructured":"Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-Perry K (2012) The consequences of chronic kidney disease on bone metabolism and growth in children. Nephrol Dial Transplant 27:3063\u20133071. https:\/\/doi.org\/10.1093\/ndt\/gfs299","journal-title":"Nephrol Dial Transplant"},{"key":"4400_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100\u2013105","journal-title":"Circulation"},{"key":"4400_CR50","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1681\/ASN.2006121397","volume":"18","author":"RC Shroff","year":"2007","unstructured":"Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996\u20133003. https:\/\/doi.org\/10.1681\/ASN.2006121397","journal-title":"J Am Soc Nephrol"},{"key":"4400_CR51","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1097\/HJH.0b013e328357c049","volume":"30","author":"S Jung","year":"2012","unstructured":"Jung S, Querfeld U, M\u00fcller D, Rudolph B, Peters H, Kr\u00e4mer S (2012) Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats. J Hypertens 30:2182\u20132191. https:\/\/doi.org\/10.1097\/HJH.0b013e328357c049","journal-title":"J Hypertens"},{"key":"4400_CR52","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40620-014-0129-1","volume":"28","author":"D Russo","year":"2015","unstructured":"Russo D, Morrone L, Di Iorio B, Andreucci M, De Gregorio MG, Errichiello C, Russo L, Locatelli F (2015) Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease. J Nephrol 28:701\u2013708. https:\/\/doi.org\/10.1007\/s40620-014-0129-1","journal-title":"J Nephrol"},{"key":"4400_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ki.1994.31","volume":"45","author":"IB Salusky","year":"1994","unstructured":"Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD. Kidney Int 45:253\u2013258","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04400-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04400-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04400-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T18:52:56Z","timestamp":1610045576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04400-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4400"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04400-w","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}